PML RARA bcr1 and bcr3 Screening Kit

PML RARA bcr1 and bcr3 Detection Kit

Historically, Acute promyelocytic leukemia (APL or AML-M3) is one of the most lethal forms of acute myeloid leukemia with distinct clinical and histopathologic features.

Acute promyelocytic leukemia is characterized by a unique chromosomal translocation involving the retinoic acid receptor-alpha gene on chromosome 17 (RARA). In greater than 99% of cases of APL, retinoic acid receptor-alpha (RARA) gene on chromosome 17 is involved in a reciprocal translocation with the promyelocytic leukemia gene (PML) on chromosome 15, a translocation denoted as t(15;17)(q22;q12)

Depending on the location of breakpoints within the PML site, intron 6, exon 6 and intron 3, the respective PML-RARa transcript subtypes referred to as long (L or bcr1), variant (V or bcr2) and short (S or bcr3), may be formed representing 55%, 5% and 40% of the cases respectively. The presence of PML/RARA t(15;17) translocation is necessary for response to all-trans-retinoic acid and arsenic trioxide. Thus, the PML/RARA t(15;17) assay is useful for diagnosis and predicting treatment response. It is also helpful for monitoring therapeutic response and MRD and for detecting early relapse.

PML RARA bcr1 and bcr3 Detection Kit Features

PML RARA bcr1 and bcr3 Detection Kit Contents

Order Information for PML RARA bcr1 and bcr3 Detection Kit

# Product Cat. No. Reaction size/kit
1 Oncoscreen PML RARA bcr1 Quantitative PCR kit OPLQ25 25
2 Oncoscreen PML RARA bcr1 Quantitative PCR kit OPLQ50 50
3 Oncoscreen PML RARA bcr1 and bcr3 Quantitative PCR kit OPLSQ25 25
4 Oncoscreen PML RARA bcr1 and bcr3 Quantitative PCR kit OPLSQ50 50
5 Oncoscreen PML RARA bcr1 and bcr3 Quantitative PCR kit OPLSQ100 100

    Talk to an advisor

    1800-210-2680

    Products
    Solutions